Patient & Visitor InformationContact Us
  • The Samuel and Esther Chester Immunology Center

  • The Viral Hepatitis Initiative at the Miriam Hospital’s Immunology Center

  • The Centers for Disease Control and Prevention (CDC) announced recently that all "baby boomers," that is, people born between 1945 and 1965, should be screened for Hepatitis C Virus (HCV) with a one-time blood test. Some "baby boomers" may have been exposed to HCV during the 1960’s to the 1980’s, a time period during which transmission of HCV was high and awareness of the virus was low. HCV was discovered in 1989. From mid-1992 onward, blood and blood products could be directly screened for HCV.

    One in 30 baby boomers has been infected with HCV, and most do not know it. Studies find that many baby boomers do not perceive themselves to be at risk and are not being tested. More than 15,000 Americans, most of them baby boomers, die each year from HCV. The CDC believes this screening initiative will address the largely preventable consequences of HCV, especially in light of newly available therapies that can cure an increasing proportion of infections. Screening baby boomers has been shown to lead to fewer cases of advanced liver disease, liver cancer and death.

    HIV, Hepatitis C and STD Testing

    The Miriam Hospital's 1125 North Main Street office offers HIV, Hepatitis C and STD testing (syphilis, gonorrhea, chlamydia). Testing is provided free for those without insurance. Testing is available on a walk-in basis every Wednesday, Thursday and Friday from 12:30 to 3:30 p.m. Other days and times are by appointment only. For more information, please call 401-793-4715.

    Visit the Rhode Island Department of Health for more HIV testing sites.  

    Clinical Trials

    Investigators at The Miriam Hospital Immunology Center have been conducting clinical trials for many years, including HCV treatment studies. Clinical trials are available for people with HCV only, and for people living with both HIV and HCV. For further information about clinical trials, please contact Patricia Delgado at 401-793-4769.